Primary chronic lymphocytic leukemia (CLL) cells from patients can be cultured in vitro and induced to proliferate when stimulated with CD40 ligand (CD40L), which induces both the classical and alternative NF-κB pathways [29], [30] (Fig. S2A). The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.